ALB and venous thromboembolism: Previous studies of COVID-19 showed that albumin was an important prognostic factor, and that a higher baseline level was associated with a decreased risk of adverse events, such as venous thromboembolism, acute respiratory distress syndrome, ICU admission, and mortality during hospitalization (Kheir et al., 2021).